Table 1.
Variables | Cases (n=141) | USP7 expression
|
P-value# | |
---|---|---|---|---|
Low (n=82) | High (n=59) | |||
Age (years) | 0.795 | |||
≤60 | 103 | 61 | 42 (40.8%) | |
>60 | 38 | 21 | 17 (44.7%) | |
FIGO stage | 0.929a | |||
I–II | 46 | 27 | 19 (41.3%) | |
III–IV | 95 | 55 | 40 (42.1%) | |
Histology type | 0.250 | |||
Serous | 121 | 68 | 53 (43.8%) | |
Non-serous | 20 | 14 | 6 (30.0%) | |
Pathological grade | 0.881b | |||
G1–G2 | 97 | 56 | 41 (42.3%) | |
G3 | 44 | 26 | 18 (40.9%) | |
Lymph node metastasis | 0.048* | |||
No | 64 | 43 | 21 (32.8%) | |
Yes | 77 | 39 | 38 (49.4%) | |
Preoperative CA-125 (U/mL) | 0.858 | |||
≤900 | 73 | 42 | 31 (42.5%) | |
>900 | 68 | 40 | 28 (41.2%) |
Notes:
Spearman’s rank correlation test.
Statistically significant.
III + IV vs I + II.
G2 + G3 vs G1.
Abbreviations: USP7, ubiquitin-specific protease 7; FIGO, International Federation of Gynecology and Obstetrics; CA, cancer antigen.